Phytantriol based smart nano-carriers for drug delivery applications

被引:73
|
作者
Akbar, Samina [1 ]
Anwar, Aneela [1 ]
Ayish, Abdullah [2 ]
Elliott, Joanne M. [3 ]
Squires, Adam M. [3 ]
机构
[1] Univ Engn & Technol, Dept Basic Sci & Humanities, KSK Campus,GT Rd, Lahore, Pakistan
[2] Avicenna Med Coll Lahore, Lahore, Pakistan
[3] Univ Reading, Dept Chem, Reading RG6 6AD, Berks, England
关键词
Phytantriol; Liquid crystal phase; Cubosomes; Hexosomes; Drug delivery; LIQUID-CRYSTALLINE PHASES; LIPID CUBIC PHASES; SUSTAINED-RELEASE; ELECTRON-MICROSCOPY; STERIC STABILIZERS; HEXAGONAL PHASES; IN-VITRO; SYSTEMS; NANOPARTICLES; CUBOSOMES;
D O I
10.1016/j.ejps.2017.01.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
From the last couple of decades, lyotropic liquid crystals have garnered enormous attentions in medical and pharmaceutical sciences. Non-toxic, chemically stable, and biocompatible properties of these liquid crystal systems are contributing to their applications for drug delivery. Among a large variety of liquid crystal phases, inverse bicontinuous cubic and inverse hexagonal mesophases have been extensively investigated for their ability to encapsulate and controlled release of bioactive molecules of various sizes and polarity. The concept of changing the drug release rate in situ by simply changing the mesophase structure is much more fascinating. The encapsulation of bioactive compounds in mesophase systems of desirable features in sub-micron sized particles such as hexosomes and cubosomes, at ambient and high temperature is bringing innovation in the development of new drug applications. This review article outlines unique structural features of cubosomes and hexosomes, their methods of productions, factors affecting their formations and their potential utilization as smart nano-carriers for biopharmaceuticals in drug delivery applications. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:31 / 42
页数:12
相关论文
共 50 条
  • [1] pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications
    Augustine, Rimesh
    Kalva, Nagendra
    Kim, Ho An
    Zhang, Yu
    Kim, Il
    MOLECULES, 2019, 24 (16):
  • [2] The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy
    Zhao, Mei-Xia
    Zhu, Bing-Jie
    NANOSCALE RESEARCH LETTERS, 2016, 11
  • [3] Active Targeted Drug Delivery for Microbes Using Nano-Carriers
    Lin, Yung-Sheng
    Lee, Ming-Yuan
    Yang, Chih-Hui
    Huang, Keng-Shiang
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (15) : 1525 - 1531
  • [4] Amphiphilic designer nano-carriers for controlled release: from drug delivery to diagnostics
    Salim, Malinda
    Minamikawa, Hiroyuki
    Sugimura, Akihiko
    Hashim, Rauzah
    MEDCHEMCOMM, 2014, 5 (11) : 1602 - 1618
  • [5] Amphiphilic block copolymer micelles with fluorescence as nano-carriers for doxorubicin delivery
    Chen, Jiucun
    Liu, Mingzhu
    RSC ADVANCES, 2014, 4 (19): : 9684 - 9692
  • [6] Innovative nano-carriers in anticancer drug delivery-a comprehensive review
    Dong, Peng
    Rakesh, K. P.
    Manukumar, H. M.
    Mohammed, Yasser Hussein Eissa
    Karthik, C. S.
    Sumathi, S.
    Mallu, P.
    Qin, Hua-Li
    BIOORGANIC CHEMISTRY, 2019, 85 : 325 - 336
  • [7] Biomedical applications of gold nanorod-based multifunctional nano-carriers
    Wang, Xin
    Shao, Mingqian
    Zhang, Song
    Liu, Xinli
    JOURNAL OF NANOPARTICLE RESEARCH, 2013, 15 (09)
  • [8] Controlled pulmonary drug and gene delivery using polymeric nano-carriers
    Beck-Broichsitter, Moritz
    Merkel, Olivia M.
    Kissel, Thomas
    JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) : 214 - 224
  • [9] Design and manufacturing of monodisperse and malleable phytantriol-based cubosomes for drug delivery applications
    Malheiros, Barbara
    de Castro, Raphael Dias
    Lotierzo, Mayra C. G.
    Casadei, Bruna R.
    Barbosa, Leandro R. S.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 61
  • [10] Antimicrobial lipids in nano-carriers for antibacterial delivery
    Zhang, Qianyu
    Wu, Wen
    Zhang, Jinqiang
    Xia, Xuefeng
    JOURNAL OF DRUG TARGETING, 2020, 28 (03) : 271 - 281